Clarius Ejection Fraction AI
by Clarius Mobile Health Corp.
510(k) K253593
Clarius Ejection Fraction AI is a medical device (FDA Class II; FDA product code QIH, Automated Radiological Image Processing Software) made by Clarius Mobile Health Corp., cleared under FDA 510(k) K253593 on 2 Mar 2026, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK253593 | Date2 Mar 2026 | StatusActive |
Official records
- FDA 510(k) database K253593
From the FDA record
- Received by the FDA
- 17 Nov 2025
- FDA decision
- 2 Mar 2026 (Substantially Equivalent)
- FDA review time
- 105 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QIH
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code QIH (Automated Radiological Image Processing Software).
- GBrain MRI by Galileo Cds, Inc.
- Imbio PHA (4.0.0) by Imbio, LLC
- BoneMRI v1.4 by Mrlguidance B.V.
- AI-CVD by HEARTLUNG CORPORATION
- EchoPAC Software Only / EchoPAC Plug-in by GE Medical Systems Ultrasound and Primary Care Diagnostics LLC
- ACUSON Sequoia Select Diagnostic Ultrasound System 11658635 by SIEMENS MEDICAL SOLUTIONS USA, INC.
- SwiftMR by AIRS Medical Inc.
- NeuroDR by Deep Reasoning Ai, Inc.
- MediAI-BA by Crescom Co., Ltd.
- MammoScreen BD by Therapixel